School of Nursing, College of Health Sciences, University of Wisconsin-Milwaukee, Milwaukee, WI, USA.
Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Child Obes. 2024 Oct;20(7):451-458. doi: 10.1089/chi.2023.0125. Epub 2024 Jan 8.
This study describes experiences and perspectives of pediatric weight management (PWM) providers on the implementation of genetic testing for rare causes of obesity. Purposive and snowball sampling recruited PWM providers via email to complete a 23-question survey with multiple choice and open-ended questions. Analyses include descriptive statistics, Fisher's exact test, one-way ANOVA with Tukey's test, and qualitative analysis. Of the 55 respondents, 80% reported ordering genetic testing. Respondents were primarily physicians (82.8%) in practice for 11-20 years (42%), identified as female (80%), White (76.4%), and non-Hispanic (92.7%) and provided PWM care 1-4 half day sessions per week. Frequently reported patient characteristics that prompted testing did not vary by provider years of experience (YOE). These included obesity onset before age 6, hyperphagia, dysmorphic facies, and developmental delays. The number of patient characteristics that prompted testing varied by YOE ( = 0.03); respondents with 6-10 YOE indicated more patient characteristics than respondents with >20 YOE (mean 10.3 vs. mean 6.2). The reported primary benefit of testing was health information for patients/families; the primary drawback was the high number of indeterminate tests. Ethical concerns expressed were fear of increasing weight stigma, discrimination, and impact on insurance coverage. Respondents (42%) desired training and guidance on interpreting results and counseling patients and families. Most PWM providers reported genetic testing as an option for patient management. Provider training in genetics/genomics and research into provider and family attitudes on the genetics of obesity and the value of genetic testing are next steps to consider.
本研究描述了儿科体重管理(PWM)提供者在实施罕见肥胖病因的基因检测方面的经验和观点。通过电子邮件有针对性和滚雪球抽样招募 PWM 提供者,让他们完成一份包含 23 个多项选择题和开放式问题的调查问卷。分析包括描述性统计、Fisher 确切检验、单向方差分析和 Tukey 检验,以及定性分析。在 55 名受访者中,80%报告了基因检测的订单。受访者主要是从业 11-20 年的医生(82.8%)(42%),性别为女性(80%),白种人(76.4%),非西班牙裔(92.7%),每周提供 1-4 次半天的 PWM 护理。经常报告的促使进行检测的患者特征不因提供者的从业年限而异。这些特征包括 6 岁以前发病的肥胖、暴食症、畸形面容和发育迟缓。促使进行检测的患者特征数量因从业年限而异( = 0.03);从业 6-10 年的受访者表示比从业超过 20 年的受访者有更多的患者特征(平均 10.3 比平均 6.2)。测试的主要好处报告为患者/家庭的健康信息;主要缺点是不确定测试数量过多。表达的伦理问题包括担心增加体重耻辱感、歧视和对保险覆盖范围的影响。受访者(42%)希望在解读结果和咨询患者和家庭方面得到培训和指导。大多数 PWM 提供者将基因检测作为患者管理的一种选择。下一步是考虑在遗传学/基因组学方面对提供者进行培训,以及研究提供者和家庭对肥胖遗传学和基因检测价值的态度。